Cargando…
DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
BACKGROUND: The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could provide new insights for therapeutic strategies in multiple myeloma (MM). Here, we e...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395780/ https://www.ncbi.nlm.nih.gov/pubmed/28420429 http://dx.doi.org/10.1186/s13045-017-0461-8 |
_version_ | 1783229933897646080 |
---|---|
author | Quwaider, Dalia Corchete, Luis A. Misiewicz-Krzeminska, Irena Sarasquete, María E. Pérez, José J. Krzeminski, Patryk Puig, Noemí Mateos, María Victoria García-Sanz, Ramón Herrero, Ana B. Gutiérrez, Norma C. |
author_facet | Quwaider, Dalia Corchete, Luis A. Misiewicz-Krzeminska, Irena Sarasquete, María E. Pérez, José J. Krzeminski, Patryk Puig, Noemí Mateos, María Victoria García-Sanz, Ramón Herrero, Ana B. Gutiérrez, Norma C. |
author_sort | Quwaider, Dalia |
collection | PubMed |
description | BACKGROUND: The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could provide new insights for therapeutic strategies in multiple myeloma (MM). Here, we explore the role of DEPTOR, an mTOR inhibitor, in the terminal differentiation of myeloma cells, and its potential impact on patient survival. METHODS: The expression level of DEPTOR in MM cell lines and B cell populations was measured by real-time RT-PCR, and/or Western blot analysis. DEPTOR protein level in MM patients was quantified by capillary electrophoresis immunoassay. RNA interference was used to downregulate DEPTOR in MM cell lines. RESULTS: DEPTOR knockdown in H929 and MM1S cell lines induced dedifferentiation of myeloma cells, as demonstrated by the upregulation of PAX5 and BCL6, the downregulation of IRF4, and a clear reduction in cell size and endoplasmic reticulum mass. This effect seemed to be independent of mTOR signaling, since mTOR substrates were not affected by DEPTOR knockdown. Additionally, the potential for DEPTOR to be deregulated in MM by particular miRNAs was investigated. The ectopic expression of miR-135b and miR-642a in myeloma cell lines substantially diminished DEPTOR protein levels, and caused dedifferentiation of myeloma cells. Interestingly, the level of expression of DEPTOR protein in myeloma patients was highly variable, the highest levels being associated with longer progression-free survival. CONCLUSIONS: Our results demonstrate for the first time that DEPTOR expression is required to maintain myeloma cell differentiation and that high level of its expression are associated with better outcome. Primary samples used in this study correspond to patients entered into GEM2010 trial (registered at www.clinicaltrials.gov as #NCT01237249, 4 November 2010). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-017-0461-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5395780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53957802017-04-20 DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma Quwaider, Dalia Corchete, Luis A. Misiewicz-Krzeminska, Irena Sarasquete, María E. Pérez, José J. Krzeminski, Patryk Puig, Noemí Mateos, María Victoria García-Sanz, Ramón Herrero, Ana B. Gutiérrez, Norma C. J Hematol Oncol Research BACKGROUND: The B cell maturation process involves multiple steps, which are controlled by relevant pathways and transcription factors. The understanding of the final stages of plasma cell (PC) differentiation could provide new insights for therapeutic strategies in multiple myeloma (MM). Here, we explore the role of DEPTOR, an mTOR inhibitor, in the terminal differentiation of myeloma cells, and its potential impact on patient survival. METHODS: The expression level of DEPTOR in MM cell lines and B cell populations was measured by real-time RT-PCR, and/or Western blot analysis. DEPTOR protein level in MM patients was quantified by capillary electrophoresis immunoassay. RNA interference was used to downregulate DEPTOR in MM cell lines. RESULTS: DEPTOR knockdown in H929 and MM1S cell lines induced dedifferentiation of myeloma cells, as demonstrated by the upregulation of PAX5 and BCL6, the downregulation of IRF4, and a clear reduction in cell size and endoplasmic reticulum mass. This effect seemed to be independent of mTOR signaling, since mTOR substrates were not affected by DEPTOR knockdown. Additionally, the potential for DEPTOR to be deregulated in MM by particular miRNAs was investigated. The ectopic expression of miR-135b and miR-642a in myeloma cell lines substantially diminished DEPTOR protein levels, and caused dedifferentiation of myeloma cells. Interestingly, the level of expression of DEPTOR protein in myeloma patients was highly variable, the highest levels being associated with longer progression-free survival. CONCLUSIONS: Our results demonstrate for the first time that DEPTOR expression is required to maintain myeloma cell differentiation and that high level of its expression are associated with better outcome. Primary samples used in this study correspond to patients entered into GEM2010 trial (registered at www.clinicaltrials.gov as #NCT01237249, 4 November 2010). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-017-0461-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-18 /pmc/articles/PMC5395780/ /pubmed/28420429 http://dx.doi.org/10.1186/s13045-017-0461-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Quwaider, Dalia Corchete, Luis A. Misiewicz-Krzeminska, Irena Sarasquete, María E. Pérez, José J. Krzeminski, Patryk Puig, Noemí Mateos, María Victoria García-Sanz, Ramón Herrero, Ana B. Gutiérrez, Norma C. DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma |
title | DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma |
title_full | DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma |
title_fullStr | DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma |
title_full_unstemmed | DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma |
title_short | DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma |
title_sort | deptor maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395780/ https://www.ncbi.nlm.nih.gov/pubmed/28420429 http://dx.doi.org/10.1186/s13045-017-0461-8 |
work_keys_str_mv | AT quwaiderdalia deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT corcheteluisa deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT misiewiczkrzeminskairena deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT sarasquetemariae deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT perezjosej deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT krzeminskipatryk deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT puignoemi deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT mateosmariavictoria deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT garciasanzramon deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT herreroanab deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma AT gutierreznormac deptormaintainsplasmacelldifferentiationandfavorablyaffectsprognosisinmultiplemyeloma |